![SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applications | bioRxiv SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applications | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2022/03/24/2022.03.24.485614/F4.large.jpg)
SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applications | bioRxiv
![PDF) SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applications PDF) SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applications](https://i1.rgstatic.net/publication/359455722_SARS-CoV-2_neutralizing_camelid_heavy-chain-only_antibodies_as_powerful_tools_for_diagnostic_and_therapeutic_applications/links/636d1f0254eb5f547cbef607/largepreview.png)
PDF) SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applications
Novel Biobased Multifunctional Emollients for Cosmetic Applications: Toward the Ingredient-List Reduction | ACS Sustainable Chemistry & Engineering
![SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applications | bioRxiv SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applications | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2022/03/24/2022.03.24.485614/F2.large.jpg)
SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applications | bioRxiv
![JCM | Free Full-Text | Predicting the Need for Renal Replacement Therapy Using a Vascular Occlusion Test and Tissue Oxygen Saturation in Patients in the Early Phase of Multiorgan Dysfunction Syndrome JCM | Free Full-Text | Predicting the Need for Renal Replacement Therapy Using a Vascular Occlusion Test and Tissue Oxygen Saturation in Patients in the Early Phase of Multiorgan Dysfunction Syndrome](https://www.mdpi.com/jcm/jcm-11-01420/article_deploy/html/images/jcm-11-01420-g001.png)